# VIVIMUSTA

NDC: 24338-270
Generic name: BENDAMUSTINE HYDROCHLORIDE
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250401

FDA application: NDA212209

## Active ingredients

- BENDAMUSTINE HYDROCHLORIDE: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24338-270"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24338-270
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4df6548f-c4ad-4eb2-a54f-19766a3d90ca